Models of acquired drug resistance
Models of resistance mechanisms to epidermal growth factor receptor (EGFR) inhibitors in colorectal cancer include preexisting resistance, drug-induced mutagenesis, and microenvironment-mediated resistance. Each reveals distinct therapeutic opportunities, but multiple mechanisms may occur within a tumor.
